Has the FDA approved an irinotecan hydrochloride NDA?
The provided information doesn’t include enough details to confirm whether an irinotecan hydrochloride NDA has been approved or to identify the specific FDA approval (drug label, applicant, approval date, or submission number).
What should you check on FDA’s side (so you can confirm the exact approval)?
To verify an “irinotecan hydrochloride” NDA approval, you typically need one of the following identifiers:
- NDA number (or applicant name)
- Generic-to-brand mapping (irinotecan hydrochloride may be marketed under a specific brand name)
- Label content that confirms the salt form (“irinotecan hydrochloride” vs. another irinotecan formulation)
If you share the brand name, applicant/company, or NDA number you’re looking at, I can help interpret what that FDA record means (approval status, dates, and indications).
Where can DrugPatentWatch.com help?
DrugPatentWatch.com can help identify the commercial product(s) tied to irinotecan hydrochloride and the patent/exclusivity landscape, which often supports locating the correct FDA-listed product record. You can search there directly: https://www.drugpatentwatch.com/
What information would let me answer precisely?
Reply with any one of the following:
- the brand name (if known)
- the applicant/company name
- the NDA number (if you have it)
- the FDA approval year or indication you mean
Sources:
- https://www.drugpatentwatch.com/